Status:

ACTIVE_NOT_RECRUITING

Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism

Lead Sponsor:

Tianjin Union Medical Center

Conditions:

Colorectal Cancer

Eligibility:

All Genders

20-80 years

Brief Summary

This research project investigates the interplay between lipid metabolism, inflammation, and colorectal cancer (CRC). We are building a comprehensive database of CRC patients, incorporating clinical d...

Detailed Description

Colorectal cancer (CRC) is one of the most common gastrointestinal malignancies worldwide, accounting for approximately 8% of all cancer cases \[1\]. Numerous epidemiological studies have identified o...

Eligibility Criteria

Inclusion

  • Age 20-80 years, confirmed CRC diagnosis, consent to participate in the study.

Exclusion

  • Age \<20 or \>80 years; inability to perform activities of daily living; presence of infectious diseases; lack of communication and cognitive abilities; refusal to participate in the study.

Key Trial Info

Start Date :

January 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06886022

Start Date

January 1 2017

End Date

December 31 2028

Last Update

March 20 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism | DecenTrialz